Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 June 2020 | Story Amanda Thongha

WATCH: Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, Prof Hendri Kroukamp, the Dean of the Faculty of Economic and Management Sciences, Susan Van Jaarveld, Senior Director at the Department of Human Sources, and Brandon Jacobs, Head of Retail and Business Banking at Standard Bank, Central Free State explain what the “I Am’ Wellness programme is about.

 

Maintaining a healthy work-life balance continues to be a juggling act for most, more so during this uncertain time dominated by COVID-19. To help individuals cope with life challenges, the University of the Free State (UFS) has launched a new short learning programme that addresses all aspects of well-being.

The ‘I Am’ Wellness short learning programme, open to UFS staff, private individuals, and businesses, kicks off on 19 June 2020. A number of prominent South Africans participating in the launch of the ‘I Am’ Wellness short learning programme are, among others, Kovsie alumna and former Miss World, Rolene Strauss; former Miss South Africa, Amy Kleinhans; and motivational speaker and author, Alison Botha. Former Public Protector Thuli Madonsela rounds off the list of public figures who have also expressed interest in the programme.

Burneline Kaars, Head of Organisational Development and Employee Wellness at the UFS, says those interested in the programme can look forward to content focusing on different topics and themes related to wellness aspects. Participants will discover the fun of finding ways to improve their health and well-being through activities, games, quizzes, and many more.

“Upon completion of this programme, participants will be equipped to understand and improve their own personal and work-related well-being. They will be empowered to increase their own well-being and reach their optimal potential in both their personal and work life.”

The programme, a joint effort of the UFS Division of Organisational Development and Employee Wellness and the UFS Department of Industrial Psychology, can be completed online or as part of contact sessions, depending on the needs of the participants. Participants need to avail themselves four hours a week to successfully complete the programme. Those who master the two-month programme will also receive a certificate of completion from the UFS.

The programme is offered to UFS staff at no cost. External audiences will pay R9 500 per person to complete the programme. Groups of 10 and more will get a special discount when signing up.

Registration for the formal programme opens on Wednesday, 24 June 2020.

For more information, contact Burneline Kaars at KaarsB@ufs.ac.za.


Other programmes done by the UFS Organisational Development and Employee Wellness office:


First #MentalHealth awareness run to Stellenbosch to bring hope
Kovsies pedal smoothie bike for #MentalHealth

 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept